Retracted: Association of upregulated Ras/Raf/ERK1/2 signaling with autism

Autism is a neurodevelopmental disorder characterized by impairments in social interaction, verbal communication and repetitive behaviors. BTBR mouse is currently used as a model for understanding mechanisms that may be responsible for the pathogenesis of autism. Growing evidence suggests that Ras/Raf/ERK1/2 signaling plays death‐promoting apoptotic roles in neural cells. Recent studies showed a possible association between neural cell death and autism. In addition, two studies reported that a deletion of a locus on chromosome 16, which includes the MAPK3 gene that encodes ERK1, is associated with autism. We thus hypothesized that Ras/Raf/ERK1/2 signaling could be abnormally regulated in the brain of BTBR mice that models autism. In this study, we show that expression of Ras protein was significantly elevated in frontal cortex and cerebellum of BTBR mice as compared with B6 mice. The phosphorylations of A‐Raf, B‐Raf and C‐Raf were all significantly increased in frontal cortex of BTBR mice. However, only C‐Raf phosphorylation was increased in the cerebellum of BTBR mice. In addition, we further detected that the activities of both MEK1/2 and ERK1/2, which are the downstream kinases of Ras/Raf signaling, were significantly enhanced in the frontal cortex. We also detected that ERK1/2 is significantly over‐expressed in frontal cortex of autistic subjects. Our results indicate that Ras/Raf/ERK1/2 signaling is upregulated in the frontal cortex of BTBR mice that model autism. These findings, together with the enhanced ERK1/2 expression in autistic frontal cortex, imply that Ras/Raf/ERK1/2 signaling activities could be increased in autistic brain and involved in the pathogenesis of autism.

[1]  Thomas Bourgeron,et al.  The Neurobiology of Autism , 2019, Autism and Pervasive Developmental Disorders.

[2]  Fei Liu,et al.  BDNF‐Akt‐Bcl2 antiapoptotic signaling pathway is compromised in the brain of autistic subjects , 2010, Journal of neuroscience research.

[3]  Jill L Silverman,et al.  Repetitive Self-Grooming Behavior in the BTBR Mouse Model of Autism is Blocked by the mGluR5 Antagonist MPEP , 2010, Neuropsychopharmacology.

[4]  D. Hewedi,et al.  Oxidative stress in Egyptian children with autism: relation to autoimmunity , 2010, Journal of Neuroimmunology.

[5]  A. Sheikh,et al.  Cathepsin D and apoptosis related proteins are elevated in the brain of autistic subjects , 2010, Neuroscience.

[6]  Y. Tesfaigzi,et al.  How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer? , 2009, Cell cycle.

[7]  Maria Luisa Scattoni,et al.  Ultrasonic vocalizations: A tool for behavioural phenotyping of mouse models of neurodevelopmental disorders , 2009, Neuroscience & Biobehavioral Reviews.

[8]  Huachen Gan,et al.  Trihydrophobin 1 Interacts with PAK1 and Regulates ERK/MAPK Activation and Cell Migration* , 2009, Journal of Biological Chemistry.

[9]  Sangita B. Patil,et al.  Elevated immune response in the brain of autistic patients , 2009, Journal of Neuroimmunology.

[10]  A. Sidhu,et al.  Dopamine promotes striatal neuronal apoptotic death via ERK signaling cascades , 2009, The European journal of neuroscience.

[11]  J. Stockman Association between Microdeletion and Microduplication at 16p11.2 and Autism , 2009 .

[12]  D. Geschwind,et al.  Advances in autism genetics: on the threshold of a new neurobiology , 2008, Nature Reviews Genetics.

[13]  P. A. Friedman,et al.  Na/H exchange regulatory factor 1, a novel AKT-associating protein, regulates extracellular signal-regulated kinase signaling through a B-Raf-mediated pathway. , 2008, Molecular biology of the cell.

[14]  K. Lu,et al.  NKCC1-mediated traumatic brain injury-induced brain edema and neuron death via Raf/MEK/MAPK cascade , 2008, Critical care medicine.

[15]  H. McFarlane,et al.  Autism‐like behavioral phenotypes in BTBR T+tf/J mice , 2008, Genes, brain, and behavior.

[16]  D. Conrad,et al.  Recurrent 16p11.2 microdeletions in autism. , 2007, Human molecular genetics.

[17]  Jacqueline N. Crawley,et al.  Social deficits in BTBR T + tf/J mice are unchanged by cross-fostering with C57BL/6J mothers , 2007, International Journal of Developmental Neuroscience.

[18]  Hewlet G McFarlane,et al.  Social Approach Behaviors are Similar on Conventional Versus Reverse Lighting Cycles, and in Replications Across Cohorts, in BTBR T+ tf/J, C57BL/6J, and Vasopressin Receptor 1B Mutant Mice , 2007, Frontiers in behavioral neuroscience.

[19]  M. Chez,et al.  Memantine as Adjunctive Therapy in Children Diagnosed With Autistic Spectrum Disorders: An Observation of Initial Clinical Response and Maintenance Tolerability , 2007, Journal of child neurology.

[20]  Jacqueline N. Crawley,et al.  Mouse behavioral tasks relevant to autism: Phenotypes of 10 inbred strains , 2007, Behavioural Brain Research.

[21]  Valerie J. Bolivar,et al.  Assessing autism-like behavior in mice: Variations in social interactions among inbred strains , 2007, Behavioural Brain Research.

[22]  K. Unsicker,et al.  Extracellular signal-regulated kinase as an inducer of non-apoptotic neuronal death , 2006, Neuroscience.

[23]  T. Bourgeron,et al.  Searching for ways out of the autism maze: genetic, epigenetic and environmental clues , 2006, Trends in Neurosciences.

[24]  J. Blenis,et al.  MAPK signal specificity: the right place at the right time. , 2006, Trends in biochemical sciences.

[25]  S. Davis,et al.  Mitogen‐activated protein kinase/extracellular regulated kinase signalling and memory stabilization: a review , 2006, Genes, brain, and behavior.

[26]  Hiroko Koike,et al.  Disc1 is mutated in the 129S6/SvEv strain and modulates working memory in mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Jareen Meinzen-Derr,et al.  Elevated cytokine levels in children with autism spectrum disorder , 2006, Journal of Neuroimmunology.

[28]  E. A. Reece,et al.  Nicotine-induced embryonic malformations mediated by apoptosis from increasing intracellular calcium and oxidative stress. , 2005, Birth defects research. Part B, Developmental and reproductive toxicology.

[29]  T. Kemper,et al.  Neuroanatomic observations of the brain in autism: a review and future directions , 2005, International Journal of Developmental Neuroscience.

[30]  A. Zimmerman,et al.  Neuroglial activation and neuroinflammation in the brain of patients with autism , 2005, Annals of neurology.

[31]  S. Canals,et al.  Role of extracellular signal‐regulated protein kinase in neuronal cell death induced by glutathione depletion in neuron/glia mesencephalic cultures , 2004, Journal of neurochemistry.

[32]  David R. Kaplan,et al.  ERK activation promotes neuronal degeneration predominantly through plasma membrane damage and independently of caspase-3 , 2004, The Journal of cell biology.

[33]  S. Fatemi,et al.  Levels of Bcl-2 and P53 Are Altered in Superior Frontal and Cerebellar Cortices of Autistic Subjects , 2003, Cellular and Molecular Neurobiology.

[34]  H. Rubinfeld,et al.  The ERK cascade as a prototype of MAPK signaling pathways. , 2004, Methods in molecular biology.

[35]  C. Pritchard,et al.  Raf proteins and cancer: B-Raf is identified as a mutational target. , 2003, Biochimica et biophysica acta.

[36]  Douglas Wahlsten,et al.  Survey of 21 inbred mouse strains in two laboratories reveals that BTBR T/+ tf/tf has severely reduced hippocampal commissure and absent corpus callosum , 2003, Brain Research.

[37]  I. Galve-Roperh,et al.  The Endocannabinoid Anandamide Inhibits Neuronal Progenitor Cell Differentiation through Attenuation of the Rap1/B-Raf/ERK Pathway* , 2002, The Journal of Biological Chemistry.

[38]  H. Jyonouchi,et al.  Innate Immunity Associated with Inflammatory Responses and Cytokine Production against Common Dietary Proteins in Patients with Autism Spectrum Disorder , 2002, Neuropsychobiology.

[39]  L. Martin,et al.  Immature and Mature Cortical Neurons Engage Different Apoptotic Mechanisms Involving Caspase-3 and the Mitogen-Activated Protein Kinase Pathway , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[40]  D. DeFranco,et al.  Prolonged Nuclear Retention of Activated Extracellular Signal-regulated Protein Kinase Promotes Cell Death Generated by Oxidative Toxicity or Proteasome Inhibition in a Neuronal Cell Line* , 2002, The Journal of Biological Chemistry.

[41]  E. Bosmans,et al.  Activation of the Inflammatory Response System in Autism , 2002, Neuropsychobiology.

[42]  S. Fatemi,et al.  Altered levels of Bcl2 and p53 proteins in parietal cortex reflect deranged apoptotic regulation in autism , 2001, Synapse.

[43]  B. Szende,et al.  Apoptosis in Various Organs of Preterm Infants: Histopathologic Study of Lung, Kidney, Liver, and Brain of Ventilated Infants , 2001, Pediatric Research.

[44]  S. Fatemi,et al.  Reduction in anti-apoptotic protein Bcl-2 in autistic cerebellum , 2001, Neuroreport.

[45]  Harumi Jyonouchi,et al.  Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression , 2001, Journal of Neuroimmunology.

[46]  Jon W. Johnson,et al.  Persistent Activation of ERK Contributes to Glutamate-induced Oxidative Toxicity in a Neuronal Cell Line and Primary Cortical Neuron Cultures* , 2000, The Journal of Biological Chemistry.

[47]  S. Fatemi,et al.  Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression , 2000, Molecular Psychiatry.

[48]  V. Singh,et al.  Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism , 1996, Journal of Neuroimmunology.

[49]  A. Kimchi,et al.  Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death. , 1995, Genes & development.

[50]  S. Nagata,et al.  Purification and characterization of the Fas-ligand that induces apoptosis , 1994, The Journal of experimental medicine.

[51]  G. Forni,et al.  Environmental signals influencing expression of the IFN-gamma receptor on human T cells control whether IFN-gamma promotes proliferation or apoptosis. , 1994, Journal of immunology.

[52]  C. Chou,et al.  In Vitro Apoptosis in the Human Hepatoma Cell Line Induced by Transforming Growth Factor β1 , 1992 .

[53]  Atsushi Hase,et al.  The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis , 1991, Cell.

[54]  C. Stoscheck,et al.  Quantitation of protein. , 1990, Methods in enzymology.

[55]  P. Möller,et al.  Monoclonal antibody-mediated tumor regression by induction of apoptosis. , 1989, Science.

[56]  L. Gooding,et al.  Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. , 1988, Journal of immunology.

[57]  A. Scheibel,et al.  Lower Purkinje cell counts in the cerebella of four autistic subjects: initial findings of the UCLA-NSAC Autopsy Research Report. , 1986, The American journal of psychiatry.

[58]  P. K. Smith,et al.  Measurement of protein using bicinchoninic acid. , 1985, Analytical biochemistry.